Elastography, a sensitive tool for the evaluation of neoadjuvant chemotherapy in patients with high‑grade serous ovarian carcinoma

  • Authors:
    • Meng Xie
    • Xuyin Zhang
    • Zhan Jia
    • Yunyun Ren
    • Wenping Wang
  • View Affiliations

  • Published online on: July 11, 2014     https://doi.org/10.3892/ol.2014.2346
  • Pages: 1652-1656
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to evaluate tumor stiffness by ultrasound elastography, which has the potential to provide additional information that is useful in predicting the response to neoadjuvant chemotherapy (NACT) in high‑grade serous ovarian carcinoma (HGSC) patients. In total, 32 patients with International Federation of Gynecology and Obstetrics stage III and IV epithelial ovarian cancer treated with NACT underwent transvaginal and transabdominal sonography, followed by elastography and finally, by interval cytoreductive surgery. Histopathological analysis revealed 24 (75%) HGSCs. The mean elasticity score was statistically higher for the post‑NACT lesions than for the pre‑NACT lesions (3.13±0.57 vs. 2.04±0.51, respectively; P<0.001). The median elasticity score for the pre‑NACT lesions on the four‑point scale was 2, and the score for the post‑NACT lesions was 4. Cases of post‑NACT with scores of 3 and 4 had a higher optimal cytoreduction rate than cases with scores of 1 and 2 (93.8 vs. 25.0%, respectively; P<0.001). When the post‑NACT elasticity scores of 3 and 4 were used for the prediction of optimal cytoreduction, elastography exhibited 88.2% sensitivity, 85.7% specificity, a 93.8% positive predictive value, a 75.0% negative predictive value and 87.5% accuracy. The results of the current study suggested that elastography is a sensitive tool for the evaluation of NACT in patients with HGSC and that it may aid gynecologists in choosing the optimal cytoreduction.
View Figures
View References

Related Articles

Journal Cover

October 2014
Volume 8 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xie M, Zhang X, Jia Z, Ren Y and Wang W: Elastography, a sensitive tool for the evaluation of neoadjuvant chemotherapy in patients with high‑grade serous ovarian carcinoma. Oncol Lett 8: 1652-1656, 2014
APA
Xie, M., Zhang, X., Jia, Z., Ren, Y., & Wang, W. (2014). Elastography, a sensitive tool for the evaluation of neoadjuvant chemotherapy in patients with high‑grade serous ovarian carcinoma. Oncology Letters, 8, 1652-1656. https://doi.org/10.3892/ol.2014.2346
MLA
Xie, M., Zhang, X., Jia, Z., Ren, Y., Wang, W."Elastography, a sensitive tool for the evaluation of neoadjuvant chemotherapy in patients with high‑grade serous ovarian carcinoma". Oncology Letters 8.4 (2014): 1652-1656.
Chicago
Xie, M., Zhang, X., Jia, Z., Ren, Y., Wang, W."Elastography, a sensitive tool for the evaluation of neoadjuvant chemotherapy in patients with high‑grade serous ovarian carcinoma". Oncology Letters 8, no. 4 (2014): 1652-1656. https://doi.org/10.3892/ol.2014.2346